Compare ANVS & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANVS | PVL |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 57.8M |
| IPO Year | 2019 | N/A |
| Metric | ANVS | PVL |
|---|---|---|
| Price | $2.57 | $1.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 314.1K | 129.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.40% |
| EPS Growth | ★ 62.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $1.30 |
| 52 Week High | $5.50 | $2.04 |
| Indicator | ANVS | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 61.33 |
| Support Level | $2.27 | $1.75 |
| Resistance Level | $2.63 | $1.88 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 33.85 | 73.09 |
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.